Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s
Journal of Chemical Information and Modeling · 2025
DOI: 10.1021/acs.jcim.5c00858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2025. Verfasst von Narayan Gautam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Central Department of Physics, Tribhuvan University, Kirtipur, Kathmandu 44613, Nepal. Hauptthemen laut MEDLINE: Histone Deacetylases, MEF2 Transcription Factors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Myocyte enhancer factor 2 (MEF2) transcription factors regulate several developmental programs, including the control of neural crest development and neuronal differentiation as well as survival. MEF2s are highly expressed in cerebellar granule neurons. Class IIa histone deacetylases (HDACs), abundantly expressed in the brain as well, repress gene expression activity of MEF2 via physical interactions and play a critical role in neuronal apoptosis. In this work, we conducted molecular dynamics (MD) simulation-based investigations to investigate interactions among different class IIa HDACs (HDAC4, HDAC5, HDAC7, and HDAC9) and MEF2s (MEF2A, MEF2B, MEF2C, and MEF2D). Our results show that hydrophobic interactions are the main mechanism for the formation of class IIa HDAC-MEF2 complexes. Our analysis shows that L66 and L67 in all MEF2s mostly contribute to the hydrophobic interactions. All residues that establish hydrophobic interactions, hydrogen bonding, and salt bridges are conserved in all MEF2s. Calculations of the MM/GBSA binding free energies also show that the class IIa HDAC-MEF2 complexes exhibit comparable binding affinities. We performed surface plasmon resonance (SPR)-based direct binding experiments using four different purified class IIa HDACs and MEF2A to validate our computational investigations. The SPR results confirmed the direct binding between the class IIa HDACs and MEF2A with fairly comparable nanomolar affinity (3.5 nM to 19.1 nM). This is a comprehensive study to map interactions among class IIa HDACs and MEF2s. We believe that our investigation offers the scientific community valuable insights to further understand, explore, and investigate biomolecular systems that include the class IIa HDAC-MEF2 complex formations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Central Department of Physics, Tribhuvan University, Kirtipur, Kathmandu 44613, Nepal.
- Tri-Chandra Multiple Campus, Tribhuvan University, Ghantaghar, Kathmandu 44613, Nepal.
- Department of Biology, Georgetown University, Washington, D.C. 20057, United States.
- Department of Oncology, Georgetown University, Washington, D.C. 20057, United States.
- Department of Physics, Florida International University, Miami, Florida 33199, United States.
- Biomolecular Sciences Institute, Florida International University, Miami, Florida 33199, United States.
ORCID-Profile: Narayan Gautam, Prem P Chapagain, Narayan P Adhikari, Purushottam B Tiwari
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Gautam, N., Wang, S., Üren, A., Chapagain, P. P., Adhikari, N. P., & Tiwari, P. B. (2025). Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c00858
Vancouver
Gautam N, Wang S, Üren A, Chapagain PP, Adhikari NP, Tiwari PB. Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s. Journal of Chemical Information and Modeling. 2025. doi:10.1021/acs.jcim.5c00858
BibTeX
@article{Gautam2025,
author = {Gautam, Narayan and Wang, Sophia and Üren, Aykut and Chapagain, Prem P and Adhikari, Narayan P and Tiwari, Purushottam B},
title = {Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
doi = {10.1021/acs.jcim.5c00858}
}
EUVIMED